Story detail
Read the key details here, then continue on the original publisher.
Oak Hill Bio, a new company backed by RA Capital and other investors, will take on Ultragenyx and Ionis in developing an Angelman syndrome medicine.
Join our channel to receive the latest headlines and breaking stories as soon as they are published.
The committee endorsed broader use of the peptides in lightly regulated compounding pharmacies that have grown into a multibillion-dollar business.
The beleaguered Sarepta Therapeutics named Michael Severino, who previously led Tessera Therapeutics, as its new CEO.
An FDA panel recommended that compounding pharmacies be allowed to make two more peptides, a step toward RFK Jr.'s goal to make them more available
Ahead of a hearing, the FDA raised questions about the benefits of a Duchenne treatment from Capricor Therapeutics, another twist for the rare disease drug.
Unsweetened sparkling water may offer a tooth-friendlier alternative to sugary soda, according to a small preliminary study tracking how different drinks change mouth acidity. Soda caused the strongest and longest drop in salivary pH, while sparkling water produced only a temporary decline before saliva restored normal conditions. Importantly, acidity remained above the level associated with enamel damage.
An FDA advisory panel serves some peptide wins, a measles record, and more health news from Morning Rounds
Comments (0)
Join the conversation. Comments are rate-limited, secured, and GDPR-compliant.
No comments yet. Be the first to share your thoughts!